What the SURMOUNT program actually tested Tirzepatide's evidence base rests on its dual-agonist mechanism, engaging both the GIP and GLP-1 receptors
Appel LJ, Miller ER III, Jee SH, Stolzenberg-Solomon R, Lin PH, Erlinger T, Nadeau MR, and Selhub J (2000)
MRC Statesboro makes losing weight enjoyable, and our team is eager to celebrate your successes along the way
Every step of the way, our skilled team of medical experts will work with you to make sure you reach your weight loss objectives
A: Side effects are rare but can include minor skin irritation
If your fatigue is severe, accompanied by chest pain, extreme dizziness, or signs of dehydration (or if it simply is not improving after two weeks) do not wait